Experiment: 6XYI

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H TOCSY	1.4 mM peptide	95% H2O/5% D2O	NULL	4.5	AMBIENT atm	303	Bruker AVANCE III 600
2	2D 1H-1H NOESY	1.4 mM peptide	95% H2O/5% D2O	NULL	4.5	AMBIENT atm	303	Bruker AVANCE III 600
3	2D 1H-15N HSQC	1.4 mM peptide	95% H2O/5% D2O	NULL	4.5	AMBIENT atm	303	Bruker AVANCE III 600
4	2D 1H-13C HSQC aromatic	1.4 mM peptide	95% H2O/5% D2O	NULL	4.5	AMBIENT atm	303	Bruker AVANCE III 600
5	2D 1H-13C HSQC aliphatic	1.4 mM peptide	95% H2O/5% D2O	NULL	4.5	AMBIENT atm	303	Bruker AVANCE III 600
6	2D DQF-COSY	1.4 mM peptide	95% H2O/5% D2O	NULL	4.5	AMBIENT atm	303	Bruker AVANCE III 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	1 (target function)

Additional NMR Experimental Information
Details	NULL

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA	3.98.13	Guntert, Mumenthaler and Wuthrich
2	chemical shift assignment	CARA	1.9.1.7	Keller and Wuthrich
3	peak picking	CARA	1.9.1.7	Keller and Wuthrich
4	data analysis	MOLMOL	2K.2	Koradi, Billeter and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.